State Street Corp Brainstorm Cell Therapeutics Inc. Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
A detailed history of State Street Corp transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 117,260 shares of BCLI stock, worth $126,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,260
Previous 117,260
-0.0%
Holding current value
$126,640
Previous $39,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BCLI
# of Institutions
42Shares Held
10.9MCall Options Held
160KPut Options Held
30.5K-
Armistice Capital, LLC New York, NY6.9MShares$7.45 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.63 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA683KShares$737,4410.0% of portfolio
-
Black Rock Inc. New York, NY386KShares$417,3270.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$367,3620.01% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $39.4M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...